youtube_live
Fitimet për Q3 2026 • pas 2 ditësh
Shiko detajetchevron_right
LLY:NYSE
Eli Lilly And Co
1Â 279,14Â US$
arrow_upward
+0,36%(+4,59) 1D
1Â 282,89Â US$
arrow_upward
+0,29% (+3,75)bedtimeJashtë orarit
Mbyllur: 26 tet, 4:00:06 m.d., GMT-4 · USD
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për LLY...
Hap
1Â 286,39Â US$
I lartë
1Â 296,90Â US$
I ulët
1Â 273,73Â US$
Kapitalizimi i tregut
1,20Â bln
Vëllimi mesatar
2,32Â mln
Vëllimi
2,11Â mln
Dividendi
0,54%
Dividendi tremujor
1,73Â US$
Data e ndërprerjes së dividendit
14 gush 2026
Raporti çmim/fitim
42,93
Maksimumi 52-javor
1Â 321,21Â US$
Minimumi 52-javor
809,63Â US$
Fitimet për aksion
29,80Â US$
Beta
0,46
Aksionet në qarkullim
941,36Â mln
Numri i punonjësve
50 mijë
Hap
1Â 286,39Â US$
I lartë
1Â 296,90Â US$
I ulët
1Â 273,73Â US$
Kapitalizimi i tregut
1,20Â bln
Vëllimi mesatar
2,32Â mln
Vëllimi
2,11Â mln
Dividendi
0,54%
Dividendi tremujor
1,73Â US$
Data e ndërprerjes së dividendit
14 gush 2026
Raporti çmim/fitim
42,93
Maksimumi 52-javor
1Â 321,21Â US$
Minimumi 52-javor
809,63Â US$
Fitimet për aksion
29,80Â US$
Beta
0,46
Aksionet në qarkullim
941,36Â mln
Numri i punonjësve
50 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
ABC17NEWS
·
4 orë më parë
AG sends cease-and-desist letter to pharmaceutical company after pricing spat with MU Health Care
Zacks
·
6 orë më parë
Don't Miss This Week's 5 Most Important Earnings Charts
Reuters
·
9 orë më parë
US judge refuses to block Eli Lilly weight-loss drug ads, rules against Novo Nordisk
Zacks
·
9 orë më parë
AI Headlines Pile Up as Wall Street Navigates a Volatile Week
Profili
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Rreth Eli Lilly And Co
Drejtori ekzekutivDavid A. Ricks
Punonjësit50 mijë
Themeluar më1876
SeliaIndianapolis, Indiana, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtililly.com